Capital Flow Monitor · Sponsors · CIK 1659073
Galvanize Therapeutics, Inc.
3200 Bridge Parkway, Redwood City, CA, 94065 · 650-268-4252
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$141.1M
Sold
$96.1M
% sold
68.1%
Investors
28
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-09-11 | D ·current | 506(b) | $141.1M | $96.1M | 68.1% | 28 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Doug Godshall — Executive Officer / Director, Redwood City, CA
1 other raise
- Saluda Medical, Inc. $30.0M of $30.0M · 100.0%
- Seth Harrison — Director, Redwood City, CA
- Jonathan Waldstreicher — Executive Officer, Redwood City, CA
- Antoine Papiernik — Director, Redwood City, CA
-
Zack Scott — Director, Redwood City, CA
2 other raises
- SetPoint Medical Corp $115.5M of $115.5M · 100.0%
- Apreo Health, Inc. $81.8M of $130.6M · 62.7%
-
David Lewis — Director, Redwood City, CA
4 other raises
- Tandigm Physician Services, LLC $219K of $219K · 100.0%
- PentaHealth, LLC $0 of —
- Oceana Australian Fixed Income Trust $716.3M of —
- DIFRATECH, INC. $500K of $3.0M · 16.7%
- Steve Anheier — Executive Officer, Redwood City, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.